Mitoguazone

Mitoguazone

Mitoguazone (pronunciation: mi-to-gua-zone) is a chemotherapy drug that is primarily used in the treatment of cancer. It is also known by its chemical name, methylglyoxal bis(guanylhydrazone).

Etymology

The term "Mitoguazone" is derived from its chemical name, methylglyoxal bis(guanylhydrazone). "Mito" is short for methylglyoxal, and "guazone" is derived from guanylhydrazone.

Usage

Mitoguazone is used in the treatment of various types of cancer, including Hodgkin's disease, non-Hodgkin's lymphoma, and acute myeloid leukemia. It works by inhibiting the growth of cancer cells, thereby slowing or stopping the progression of the disease.

Side Effects

Like many chemotherapy drugs, Mitoguazone can have a number of side effects. These can include nausea, vomiting, diarrhea, and hair loss. More serious side effects can include anemia, neutropenia, and thrombocytopenia.

Related Terms

• Chemotherapy
• Cancer
• Hodgkin's disease
• Non-Hodgkin's lymphoma
• Acute myeloid leukemia
• Nausea
• Vomiting
• Diarrhea
• Hair loss
• Anemia
• Neutropenia
• Thrombocytopenia

External links

• Medical encyclopedia article on Mitoguazone
• Wikipedia's article - Mitoguazone

This WikiMD article is a stub. You can help make it a full article.

---

Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski